• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: SOV dilatation in TAVI patients.
 

Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: SOV dilatation in TAVI patients.

Options
  • Details
  • Files
BORIS DOI
10.48350/161356
Publisher DOI
10.1016/j.ahj.2021.11.004
PubMed ID
34788603
Description
BACKGROUND

Ascending aortic root anatomy is routinely evaluated on pre-procedural multi-detector computed tomography (MDCT). However, its clinical significance has not been adequately studied. We aimed to investigate the impact of the sinus of Valsalva (SOV) dimension on clinical outcomes in patients undergoing transcatheter aortic valve implantation (TAVI).

METHODS

In a prospective TAVI registry, we retrospectively assessed SOV dimensions by pre-procedural MDCT. Patients were stratified according to tertiles of SOV diameter indexed to body surface area (SOVi). The primary endpoint was all-cause mortality at 1 year.

RESULTS

Among 2066 consecutive patients undergoing TAVI between August 2007 and June 2018, 1554 patients were eligible for the present analysis. Patients in the large SOVi group were older (83 ± 6 vs. 82 ± 6 vs. 81 ± 6; P <0.001) and had a higher Society of Thoracic Surgeons Predicted Risk of Mortality (6.3 ± 3.8 vs. 5.1 ± 3.1 vs.4.9 ± 3.5; P <0.001) than those in the other groups. Patients in the large SOVi group had a higher incidence of moderate or severe paravalvular regurgitation (11.9% vs. 4.5% vs. 3.5%; P <0.001). At 1 year, a large SOVi was independently associated with an increased risk of mortality (HR: 1.62; 95% CI: 1.19-2.21; P = 0.002) and major or life-threatening bleeding (HR: 1.30; 95% CI: 1.02-1.65; P = 0.035).

CONCLUSIONS

Dilatation of the aortic root at the SOV was associated with adverse outcomes after TAVI. The assessment of the aortic root should be integrated into the risk stratification system in patients undergoing TAVI.
Date of Publication
2022-02
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Keyword(s)
Aortic root Aortic stenosis Multi-detector computed tomography Sinus of Valsalva Transcatheter aortic valve implantation
Language(s)
en
Contributor(s)
Tomii, Daijiro
Okuno, Taishi
Universitätsklinik für Kardiologie
Heg, Dierik Hansorcid-logo
Clinical Trials Unit Bern (CTU)
Gräni, Christoph
Universitätsklinik für Kardiologie
Lanz, Jonas
Universitätsklinik für Kardiologie
Praz, Fabien Daniel
Universitätsklinik für Kardiologie
Stortecky, Stefan
Universitätsklinik für Kardiologie
Windecker, Stephan
Universitätsklinik für Kardiologie
Pilgrim, Thomas
Universitätsklinik für Kardiologie
Reineke, David Christian
Universitätsklinik für Herz- und Gefässchirurgie
Additional Credits
Universitätsklinik für Kardiologie
Universitätsklinik für Herz- und Gefässchirurgie
Clinical Trials Unit Bern (CTU)
Series
American Heart Journal
Publisher
Elsevier
ISSN
0002-8703
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo